{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:26:47Z","timestamp":1761182807852,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1007\/s10156-004-0363-x","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T11:23:11Z","timestamp":1114600991000},"page":"101-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vitro susceptibility of clinical isolates of Brucella melitensis to fucidic acid"],"prefix":"10.1016","volume":"11","author":[{"given":"Ilhami","family":"Celik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Cihangiroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Affan","family":"Denk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-004-0363-X_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"10.1007\/s10156-004-0363-X_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/AAC.43.1.194","article-title":"In vitro activities of six new fluoroquinolones against Brucella melitensis","volume":"43","author":"Trujillano-Martin","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-004-0363-X_bib0015","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jac\/23.3.433","article-title":"Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study","volume":"23","author":"Acocella","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-004-0363-X_bib0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1128\/AAC.39.5.1194","article-title":"Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones","volume":"39","author":"Garc\u00eda-Rodr\u00edguez","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-004-0363-X_bib0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1128\/AAC.37.4.911","article-title":"In vitro activities of new macrolides and rifapentine against Brucella spp","volume":"37","author":"Garcia-Rodriguez","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1007\/s10156-004-0363-X_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0924-8579(98)00073-9","article-title":"Fucidic acid in vitro activity","volume":"12","author":"Collignon","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1007\/s10156-004-0363-X_bib0035","series-title":"Manual of clinical microbiology","first-page":"549","article-title":"Brucella","author":"Moyer","year":"1995"},{"year":"2003","series-title":"Methods for dilution antimicrobial susceptibilitiy test for bacteria that grow aerobically: approved, standard","key":"10.1007\/s10156-004-0363-X_bib0040"},{"key":"10.1007\/s10156-004-0363-X_bib0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jac\/42.2.221","article-title":"The effect of dicloxacillin and fucidic acid on the extracellular and intracellular killing of Staphylococcus aureus","volume":"42","author":"Nielsen","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s10156-004-0363-X_bib0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1699-0463.1991.tb05185.x","article-title":"The effect of antistaphylococcal agents used alone and in combinations on the survival of Staphylococcus aureus ingested by human polymorphonuclear leukocytes","volume":"99","author":"Roder","year":"1991","journal-title":"APMIS"},{"key":"10.1007\/s10156-004-0363-X_bib0055","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1128\/AAC.37.9.1997","article-title":"Susceptibility of Mycobacterium kansasii to ofloxacin, sparfloxacin, clarithromycin, azithromycin, and fucidic acid","volume":"37","author":"Witzig","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-004-0363-X_bib0060","first-page":"525","article-title":"Brucella","volume":"1","author":"Shapiro","year":"1999"},{"key":"10.1007\/s10156-004-0363-X_bib0065","first-page":"636","article-title":"Susceptibility of Mexican Brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis","volume":"36","author":"Lopez-Merino","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1007\/s10156-004-0363-X_bib0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijantimicag.2003.09.024","article-title":"In vitro antimicrobial susceptibility of Brucella species","volume":"23","author":"Baykam","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1007\/s10156-004-0363-X_bib0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1469-0691.2002.00416.x","article-title":"In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey","volume":"8","author":"Kocagoz","year":"2002","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X05710138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X05710138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-004-0363-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:44:28Z","timestamp":1761158668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X05710138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005]]}},"alternative-id":["S1341321X05710138"],"URL":"https:\/\/doi.org\/10.1007\/s10156-004-0363-x","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2005]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro susceptibility of clinical isolates of Brucella melitensis to fucidic acid","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-004-0363-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}